A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
Recruiting · NCT06436677 · Registry updated 2024-05-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Sezary syndrome, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mycosis fungoides, neoplasm, primary cutaneous T-cell non-Hodgkin lymphoma | Recruiting | Not stated | 2024-05-31 | NCT06436677 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peking University Cancer Hospital & Institute | 189 |
| Peking University First Hospital | 225 |
| Peking University Third Hospital | 243 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |
| Peking University First Hospital | Beijing | China | 163 |
| Peking University Third Hospital | Beijing | China | 123 |